Cases & Deals

  • Home
  • Practices
  • Mainstay Medical International completes €30.1 million issue of shares to new and existing shareholders

Share

Mainstay Medical International completes €30.1 million issue of shares to new and existing shareholders

February 2018

Client(s) Mainstay Medical International Plc

Jones Day advised Mainstay Medical International plc, an Irish medical device company listed on Euronext Paris and the ESM of the Irish Stock Exchange, in connection with its €30.1 million (US$37.1 million) financing through the issue of shares to new and existing shareholders, primarily institutions in Europe and North America, including the Ireland Strategic Investment Fund (ISIF).

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.